These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 1665407

  • 1. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE.
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA, Cowan P, Patrick AW, Clarke BF.
    Nephrol Dial Transplant; 1993 Sep; 8(3):200-5. PubMed ID: 8385284
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
    Ribstein J, Mimran A.
    Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
    [Abstract] [Full Text] [Related]

  • 12. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S.
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL.
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [Abstract] [Full Text] [Related]

  • 14. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 15. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy.
    Pedersen MM, Hansen KW, Schmitz A, Sørensen K, Christensen CK, Mogensen CE.
    Kidney Int; 1992 Apr; 41(4):883-90. PubMed ID: 1355149
    [Abstract] [Full Text] [Related]

  • 16. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S.
    Scand J Urol Nephrol Suppl; 1990 Apr; 126():1-51. PubMed ID: 2194280
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive treatment inhibiting the progression of diabetic nephropathy.
    Mogensen CE.
    Acta Endocrinol Suppl (Copenh); 1980 Apr; 238():103-8. PubMed ID: 6933807
    [Abstract] [Full Text] [Related]

  • 18. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH, Nawaz MK, Ali JH, Al-Suhaili AR, Abu-Jayyab AK.
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [Abstract] [Full Text] [Related]

  • 19. Nephroprotection by antihypertensive agents.
    Schmieder RE.
    J Cardiovasc Pharmacol; 1994 Jan; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [Abstract] [Full Text] [Related]

  • 20. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
    Nielsen SE, Persson F, Frandsen E, Sugaya T, Hess G, Zdunek D, Shjoedt KJ, Parving HH, Rossing P.
    Diabet Med; 2012 Aug; 29(8):e184-90. PubMed ID: 22268920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.